Trending Stocks In Indian Stock Market To Bet On 15th May 2024
Chaltel Hotels at Stock Market
Chalet Hotels Ltd.
Rs.765/-
Chalet Hotels Ltd experienced significant revenue and profit growth in Q4 FY24.
Despite a –5.81% decline in the last week, its long-term performance shows a remarkable 450.88% increase over three years.
Analysts recommend buying, indicating positive market sentiment towards Chalet.
Investors interested in the hospitality sector’s growth opportunities should consider investing in Chalet for its promising future prospects.
Canara Bank at Stock Market
Canara Bank: Boost in Trading Activity
Rs.118/-
Canara Bank’s recent stock split, with a ratio of 1:5, led to a surge of 4.8% in its stock value.
This move is anticipated to amplify trading activities, attracting a broader base of retail investors.
Inclusion of Canara Bank in MSCI indices is projected to attract foreign investments worth $2 billion into the domestic equities market.
Over the last three years, CANBK has delivered impressive returns of 272.31%, indicating its strong performance and potential for growth.
Jubilant Ingrevia at Stock Market
JUBILANT INGREVIA: Mixed Q4 Results
Rs.549/-
Jubilant Ingrevia Ltd witnessed a significant increase of 7.47% in its stock value.
However, the company reported a 44% decline in Q4 profits, falling short of expectations.
Despite the profit downturn, Jubilant Ingrevia remains optimistic about sequential improvements across all three segments in FY24.
The focus on customer-centric strategies and expanding product offerings underscores the company’s commitment to long-term growth.
The board of directors has recommended a final dividend of Rs 2.50 per equity share for FY24, indicating confidence in the company’s financial stability.
Over the last year, JUBLINGREA has delivered returns of 23.39%, reflecting its resilience amidst market fluctuations.
Archean Chemical at Stock Market
Archean Chemical Industries Ltd : Decrease in Net Profit
Rs.619/-
Archean Chemical Industries Ltd witnessed a decline of 4.15% in its stock value.
The company reported a substantial 56.4% decrease in net profit, amounting to Rs 59.64 crore in Q4 FY24 compared to the same period in FY23.
This decline in profit was accompanied by a 25.9% decrease in net sales, totaling Rs 283.39 crore in Q4 FY24.
For the full fiscal year FY24, Archean Chemical reported a net profit of Rs 322.35 crore, reflecting a 16% decline compared to the previous year.
Similarly, the company’s net sales for FY24 stood at Rs 1,329.58 crore, down by 7.7% year-on-year.
Despite the decline in financial performance, ACI managed to deliver returns of 20.12% over the last year, showcasing its resilience in the market.
Siemens Ltd at Stock Market
SIEMENS: Stellar Q4 Performance
Rs.7,139/-
Siemens Ltd saw a notable increase of 6.64% in its stock value.
The company reported a remarkable 70% year-on-year rise in net profit for Q4FY24, surpassing market expectations.
In addition to strong financial results, Siemens announced a fresh capital expenditure (capex) exceeding Rs. 500 crore.
Furthermore, the company revealed plans to demerge its energy business into a separate legal entity, signaling strategic restructuring.
Leading financial firms Jefferies and Motilal Oswal Financial Services raised their target prices on Siemens stock to Rs. 8,000 and Rs. 7,800 respectively, reflecting bullish sentiment.
Over the past five years, SIEMENS has delivered exceptional returns of 507.54%, highlighting its consistent performance and investor confidence.
Aarti Industries at Stock Market
Aarti Industries Ltd: Mixed Ratings
Rs.621.45/-
Aarti Industries Ltd experienced a decline of 4.57% in its stock value.
Emkay Global Financial Services has a bullish outlook on Aarti Industries, issuing a buy call with a target price of Rs 800.
Despite a mixed performance, Aarti’s Q4 EBITDA met expectations, and management maintained its FY25 EBITDA guidance at Rs 14.5-17 billion.
However, Prabhudas Lilladher recommends a ‘Reduce’ rating for Aarti Industries, citing weakness in demand specifically within the agrochemical segment.
Over the past year, AARTIIND has delivered returns of 32.5%, indicating investor interest amidst varying analyst sentiments.
Aarti Pharmalabs Ltd : Strong Q4 Performance
Rs.586.15/-
Aarti Pharmalabs Ltd saw a decrease of 4.89% in its stock value.
The company reported a robust 52% year-on-year growth in net profit for Q4FY24, contributing to an uptick in its share price.
Additionally, Aarti Pharmalabs declared a dividend payout of Rs.1 per equity share for FY24, reflecting its commitment to rewarding shareholders.
Aarti Pharmalabs is actively engaged in the development of over 50 new products, demonstrating its focus on innovation and expansion.
With 50% of its revenue generated from export sales, the company showcases its strong presence in the global market.
Over the past year, AARTIPHARM has delivered returns of 36.53%, indicating investor confidence amidst positive financial performance.
CIPLA: Promoter Stake Sale
Rs.1405.50/-
Cipla Ltd witnessed a positive increase of 3.83% in its stock value.
Cipla promoters sold a 2.53% stake for philanthropic purposes, resulting in a stock surge of over 5%.
Despite the stake sale, the entire promoter group maintains a significant 31.67% ownership in the company, ensuring continuity and stability.
Cipla reported an impressive 78% rise in consolidated net profit for Q4 FY24, indicating strong operational performance.
Over the past year, CIPLA has delivered returns of 53.3%, reflecting investor confidence amidst strategic initiatives and positive financial results.
BUTTERFLY: Decline in Revenue and Profits
Rs.760.90/-
Butterfly Gandhimathi Appliances Ltd observed a decline of 3.93% in its stock value.
The company reported a decrease in both revenue and profits for FY24 and Q4FY24, indicating challenges in its financial performance.
Thiyagu P S, Head of R&D, resigned from his position citing personal and professional reasons, potentially impacting the company’s future research and development initiatives.
The resignation introduces uncertainty regarding the continuity of the company’s R&D plans, raising concerns among investors about its innovation capabilities.
Despite recent setbacks, BUTTERFLY has delivered impressive returns of 392.93% over the last five years, showcasing its historical growth and market potential.
Oberoi Realty Ltd: Stellar Q4 Performance
Rs.1574.25/-
Oberoi Realty Ltd experienced a notable increase of 4.76% in its stock value.
The company reported a significant 64% year-on-year increase in net profit for Q4FY24, surpassing market expectations.
Oberoi Realty’s board approved the issuance of Non-Convertible Debentures (NCDs) worth Rs. 20,000 crore on a private placement basis, indicating strategic financial planning.
The approval for NCD issuance is expected to pave the way for future revenue growth opportunities, enhancing the company’s financial flexibility.
Over the past three years, OBEROIRLTY has delivered impressive returns of 178.06%, reflecting its consistent growth trajectory and investor confidence.
EDELWEISS: Positive Q4 Performance
Rs.78.50/-
Edelweiss Financial Services Ltd witnessed a 6.1% increase in its stock value.
The company reported a notable 13.3% year-on-year rise in net profit, reaching Rs. 169.1 crore for Q4FY24, indicating robust financial performance.
Despite a slight 1.5% drop in revenue from operations to Rs. 2,967.3 crore, Edelweiss’s EBITDA surged by 13.2% to Rs. 387 crore in Q4FY24, showcasing operational strength.
Over the past year, EDELWEISS has delivered returns of 25.33%, underlining investor confidence amidst positive financial outcomes.
THERMAX: Surging Stock Amid Analyst Concerns
Rs.5080/-
Thermax Ltd experienced a significant surge of 8.49% in its stock value.
Despite concerns regarding valuations and medium-term return ratios, Thermax’s stock rallied by 19% in just four days, reflecting investor optimism.
Analysts have issued price targets with up to 27% potential downside on the stock due to anticipated incremental investments impacting return ratios in the medium term.
Despite analyst concerns, THERMAX has delivered impressive returns of 90.79% over the last year, indicating strong performance and investor confidence amidst market fluctuations.
Colgate-Palmolive (India) Ltd witnessed a decline of 3.15% in its stock value.
The company reported a commendable 20.1% year-on-year increase in net profit, totaling Rs. 379.8 crore for Q4 FY24, indicating robust financial performance.
Colgate-Palmolive’s domestic sales grew by 10.7% during the quarter, driven by positive signs of demand recovery in rural markets.
To reward shareholders, the board declared a second interim dividend of Rs. 26 per share along with a one-time special interim dividend of Rs. 10 per share, reflecting confidence in the company’s financial strength.
Over the past year, COLPAL has delivered returns of 70.85%, demonstrating its resilience and attractiveness to investors amidst strong performance in the market.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of News Lounge 24×7. We advise investors to check with certified experts before taking any investment decisions.
View Comments
Good information on stocks